DRD2 and psychiatric disorder: The mechanism underlying psychiatric adverse events (AEs) caused by ALK inhibitors remains unclear, despite ALK’s involvement in regulating the dopamine D2 receptor (D2R), which is implicated in psychiatric disorders [38].